Skip to main content
. Author manuscript; available in PMC: 2017 Feb 15.
Published in final edited form as: Heart. 2015 Nov 13;102(4):278–284. doi: 10.1136/heartjnl-2015-308403

Table 1.

Subject characteristics

Controls HFpEF P-value
Subjects, N (males:females) 24 (10:14) 24 (10:14) ---
Age, yrs 69 ± 2 69 ± 2 0.87
Body mass, kg 76 ± 3 101 ± 6 * <0.001
Stature, cm 170 ± 2 169 ± 3 0.83
Body mass index, kg/m2 28 ± 3 35 ± 1 * 0.03
Body surface area, m2 1.90 ± 0.04 2.21 ± 0.07 * <0.001
Heart rate, beats/min 62 ± 2 65 ± 2 0.25
Mean arterial blood pressure, mmHg 98 ± 2 90 ± 2 * 0.01
Glucose, mg/dL 84 ± 2 120 ± 10 * <0.001
Cholesterol, mg/dL 201 ± 9 163 ± 10 * 0.01
High-density lipoprotein, mg/dL 51 ± 3 49 ± 4 0.98
Low-density lipoprotein, mg/dL 125 ± 6 91 ± 9 * <0.01
Triglycerides, mg/dL 149 ± 17 145 ± 20 0.89

HFpEF, heart failure with preserved ejection fraction. Data are mean ± SEM.

*

Significantly different from Controls.

HHS Vulnerability Disclosure